Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil in laparoscopic cholecystectomy
ChiCTR2500105889Phase 4Recruiting
- Sponsor
- People's Hospital of Qiandongnan Miao and Dong Autonomous Prefecture
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by People's Hospital of Qiandongnan Miao and Dong Autonomous Prefecture. Primary endpoint: Postoperative nausea and vomiting incidence. Started Jul 2025; status: recruiting.
02
Drugs
oliceridine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2500105889.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500105889.